Cargando…

Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus

BACKGROUND: Chronic inflammation has been associated with insulin resistance and related metabolic dysregulation, including type 2 diabetes mellitus (T2DM). Several non modifiable (i.e. genetic predisposition) and modifiable (i.e. sedentary lifestyle, energy-dense food) risk factors were suggested t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellulu, Mohammed S., Samouda, Hanen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740444/
https://www.ncbi.nlm.nih.gov/pubmed/34991564
http://dx.doi.org/10.1186/s12902-021-00925-0
_version_ 1784629314643296256
author Ellulu, Mohammed S.
Samouda, Hanen
author_facet Ellulu, Mohammed S.
Samouda, Hanen
author_sort Ellulu, Mohammed S.
collection PubMed
description BACKGROUND: Chronic inflammation has been associated with insulin resistance and related metabolic dysregulation, including type 2 diabetes mellitus (T2DM). Several non modifiable (i.e. genetic predisposition) and modifiable (i.e. sedentary lifestyle, energy-dense food) risk factors were suggested to explain the mechanisms involved in the development of inflammation, but are difficult to assess in clinical routine. The present study aimed to identify easy to asses clinical and biological risk factors associated with inflammation in patients with T2DM. METHODS: One hundred nine patients (51 men, 58 women), 28–60 years old, from seven primary healthcare centers in Gaza City, Palestine, took part to the cross-sectional study (November 2013–May 2014). Study participants had T2DM with no history of inflammatory diseases, cardiovascular diseases, medication and/or any health condition that might affect the inflammatory markers, interleukin 6 (IL-6) and C-reactive protein (CRP). Inflammation was defined for IL-6 ≥ 2 pg/mL and CRP ≥ 6 mg/L. Multivariable logistic regressions were used to identify the relationship between inflammation and clinical and biological risk factors. RESULTS: After adjustment for age and gender, inflammation seems to increase with increased body mass index (BMI) (OR: 1.427 [1.055–1.931]), increased fasting blood glucose (OR: 1.029 [1.007–1.052]) and decreased adiponectin values (OR: 0.571 [0.361–0.903]). There were also significant relationships between inflammation and BMI (OR: 1.432 [1.042–1.968]), fasting blood glucose (OR: 1.029 [1.006–1.052]) and adiponectin (OR: 0.569 [0.359–0.902]), after adjustment for smoking habits and physical activity. CONCLUSION: Managing obesity and associated complications (i.e. hyperglycemia, high adiponectin levels) might help decreasing inflammation in individuals with T2DM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00925-0.
format Online
Article
Text
id pubmed-8740444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87404442022-01-07 Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus Ellulu, Mohammed S. Samouda, Hanen BMC Endocr Disord Research Article BACKGROUND: Chronic inflammation has been associated with insulin resistance and related metabolic dysregulation, including type 2 diabetes mellitus (T2DM). Several non modifiable (i.e. genetic predisposition) and modifiable (i.e. sedentary lifestyle, energy-dense food) risk factors were suggested to explain the mechanisms involved in the development of inflammation, but are difficult to assess in clinical routine. The present study aimed to identify easy to asses clinical and biological risk factors associated with inflammation in patients with T2DM. METHODS: One hundred nine patients (51 men, 58 women), 28–60 years old, from seven primary healthcare centers in Gaza City, Palestine, took part to the cross-sectional study (November 2013–May 2014). Study participants had T2DM with no history of inflammatory diseases, cardiovascular diseases, medication and/or any health condition that might affect the inflammatory markers, interleukin 6 (IL-6) and C-reactive protein (CRP). Inflammation was defined for IL-6 ≥ 2 pg/mL and CRP ≥ 6 mg/L. Multivariable logistic regressions were used to identify the relationship between inflammation and clinical and biological risk factors. RESULTS: After adjustment for age and gender, inflammation seems to increase with increased body mass index (BMI) (OR: 1.427 [1.055–1.931]), increased fasting blood glucose (OR: 1.029 [1.007–1.052]) and decreased adiponectin values (OR: 0.571 [0.361–0.903]). There were also significant relationships between inflammation and BMI (OR: 1.432 [1.042–1.968]), fasting blood glucose (OR: 1.029 [1.006–1.052]) and adiponectin (OR: 0.569 [0.359–0.902]), after adjustment for smoking habits and physical activity. CONCLUSION: Managing obesity and associated complications (i.e. hyperglycemia, high adiponectin levels) might help decreasing inflammation in individuals with T2DM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00925-0. BioMed Central 2022-01-06 /pmc/articles/PMC8740444/ /pubmed/34991564 http://dx.doi.org/10.1186/s12902-021-00925-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ellulu, Mohammed S.
Samouda, Hanen
Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title_full Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title_fullStr Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title_full_unstemmed Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title_short Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
title_sort clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740444/
https://www.ncbi.nlm.nih.gov/pubmed/34991564
http://dx.doi.org/10.1186/s12902-021-00925-0
work_keys_str_mv AT ellulumohammeds clinicalandbiologicalriskfactorsassociatedwithinflammationinpatientswithtype2diabetesmellitus
AT samoudahanen clinicalandbiologicalriskfactorsassociatedwithinflammationinpatientswithtype2diabetesmellitus